Alissa Evans
Acute Care · Norfolk, NENPI 1750057774
Payments from drug & device makers
What this record shows
This record is dominated by travel and lodging: $3,744 of the $5,480 with a category attached, or 68.3%. 12 manufacturers reported payments, led by Boston Scientific at 32.4% of the total. Reporting peaked in 2024 at $4,965 and has fallen 96.8% since, to $158 in 2025. Among acute care clinicians in NE with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 65 payments — averaging $84.31 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Boston Scientific$2K
- Abbott$2K
- Medtronic$1K
- Nevro Corp.$149
- Abiomed$139
- AbbVie$98
- plus $251 from 6 others
What the payments were for
- Travel & lodging$3,74468%
- Food & beverage$1,69131%
- Education$451%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Boston Scientific | 10 | $1,775 |
| Abbott | 22 | $1,608 |
| Medtronic | 13 | $1,459 |
| Nevro Corp. | 1 | $149 |
| Abiomed | 1 | $139 |
| AbbVie | 6 | $98 |
| Forte Bio-pharma LLC | 3 | $83 |
| Lilly USA, LLC | 3 | $51 |
| Relievant Medsystems, Inc. | 2 | $34 |
| Heron Therapeutics, Inc. | 1 | $32 |
| Si-bone, Inc. | 2 | $29 |
| Pfizer | 1 | $22 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Intracept$1,529
- PROCLAIM$1,137
- SYNCHROMEDII$1,019
- Omnia$149
- INTELLIS ADAPTIVESTIM$126
How this compares
$5,480 in reported general payments places this provider in the 90th percentile of 103 acute care providers in Nebraska.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 143 | $4,493 |
| Gabapentin | 269 | $2,896 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 71 | $1,570 |
| Pregabalin | 115 | $1,447 |
| Celecoxib | 47 | $1,347 |
| Oxycodone Hcl | 68 | $1,199 |
| Tramadol Hcl | 145 | $1,137 |
| Fentanyl | 12 | $1,060 |
| Duloxetine Hcl | 30 | $893 |
| Cyclobenzaprine Hcl | 53 | $516 |
| Meloxicam | 49 | $311 |
| Morphine Sulfate | 21 | $283 |
| Amitriptyline Hcl | 33 | $218 |
| Tizanidine Hcl | 22 | $202 |
| Morphine Sulfate ErMorphine Sulfate | 11 | $175 |
Paid to pharmacies, not to this prescriber.
Other acute care in Norfolk
- Jenna WittNorfolk$3K
- Stacy NelsonNorfolk$1K
- Sandra QualsetNorfolk$920
- William SaalfeldLincoln$115K
- Amanda GrosseKearney$10K
- Jennifer BecherOmaha$7K
- Mary LauerOmaha$7K
- Susan SchoenemanScottsbluff$6K
- Rachel RagerOmaha$6K
- Sarah SchroederLincoln$6K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.